COMPOUND W
Country: Írland
Tungumál: enska
Heimild: HPRA (Health Products Regulatory Authority)
Vara einkenni
(SPC)
30-04-2024
Sum skjöl fyrir þessa vöru eru ekki tiltæk eins og er, þú getur sent beiðni til þjónustu við viðskiptavini okkar og við munum láta þig vita um leið og við getum fengið þau.
Senda beiðni.
Senda beiðni.
Virkt innihaldsefni:
SALICYLIC ACID
Fáanlegur frá:
Seton Products Ltd
Skammtar:
17.0%w/w %w/w
Lyfjaform:
Cutaneous Solution
Leyfisdagur:
1998-04-01
Vara einkenni
PART II
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Compound W Liquid Wart Remover
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Salicylic Acid 17.0 % w/w.
_For excipients, see 6.1._
3 PHARMACEUTICAL FORM
Cutaneous Solution.
Faintly yellow viscous cutaneous solution.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
As a keratolytic for treatment of warts and verrucae
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
Adults and children over 6 years of age:
Gently rub the hard skin from the surface of the wart with a pumice stone or emery board. Apply to wart one drop at a
time with dropper-rod until wart is covered. Allow to dry completely. Avoid surrounding skin. Repeat application
daily, with regular washing, for up to four weeks.
4.3 CONTRAINDICATIONS
Do not use Compound W Liquid Wart Remover on moles, birth marks, genital or facial warts.
Not to be used on children under 6 years except on medical advice
.
4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE
If there is doubt as to the diagnosis consult the doctor.
Patients with diabetes should consult their doctor about foot problems.
Avoid contact with the eyes, mouth or mucous membranes.
Do not apply to healthy skin or skin which is inflamed or broken. If Compound W Liquid Wart Remover touches
healthy skin, wash off immediately with plenty of water.
If there is no improvement, or aggravation of the condition, the doctor should be consulted.
Flammable product: Keep away from naked flames.
IRISH MEDICINES BOARD
________________________________________________________________________________________________________________________
_Date Printed 01/03/2010_
_CRN 2078998_
_page number: 1_
For external use only
4.5 INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF INTERACTION
None stated.
4.6 PREGNANCY AND LACTATION
No con
Lestu allt skjalið
